Accès ouvert
2026
article
OpenAlex
Juliette Léon, Elise Ducrocq, Marie-Camille Lafargue, Dominique Bertrand et autres
Introduction Recurrent focal segmental glomerulosclerosis (rFSGS) is a severe complication after kidney transplantation, often resistant to standard therapies and requiring prolonged apheresis. Combined depletion of plasma cells (anti-CD38) and B cells (anti-CD20) has emerged as a potential strategy, but multicenter real-world data …
fr, us, re
(code pays fourni par la source)
2025
article
OpenAlex
Marie-Camille Lafargue, Frank E. Hullekes, Rucháma Verhoeff, Christian LeGuern et autres
Background: Recurrent primary FSGS (pFSGS) remains a devastating complication in kidney transplantation (KTx), often culminating in early allograft loss. Despite decades of research, precise biomarkers for disease activity and recurrence risk remain elusive. Anti-nephrin antibodies, recently implicated in the pathogenesis of a …
us
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Sul A Lee, Marie-Camille Lafargue, Winfred W. Williams, Kassem Safa et autres
Kidney allotransplantation remains the preferred treatment for end-stage kidney disease, yet donor shortages limit its availability. Xenotransplantation using genetically modified porcine kidneys offers a promising alternative. Here, we report key physiological observations from the first-in-human porcine kidney xenograft over a 51 day …
us, fr
(code pays fourni par la source)
2025
article
OpenAlex
Sylvain Bodard, Theodore T. Pierce, Madeleine Sertic, Marie-Camille Lafargue et autres
fr, us
(code pays fourni par la source)
2024
article
OpenAlex
Pauline Corbaux, Matthieu Bainaud, Adrien Rousseau, Mélanie Try et autres
fr
(code pays fourni par la source)
2024
article
OpenAlex
Sul A Lee, Marie-Camille Lafargue, Winfred W. Williams, Hannah M. Gilligan et autres
Background: Although kidney transplantation is the preferred treatment for ESKD, organ shortages severely limit timely access to transplants. Pig-to-human xenotransplantation has been proposed to address this issue, but concerns remain about meeting the physiologic needs of a living human and the potential …
us
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Marie-Camille Lafargue, Jean–Paul Duong Van Huyen, Helmut G. Rennke, Marie Essig et autres
Introduction: The objective of this study was to describe kidney involvement in patients with myelodysplastic syndromes (MDS), their treatments, and outcomes. Methods: We conducted a multicenter retrospective study in seven centers, identifying MDS patients with acute kidney injury (AKI), chronic kidney disease …
fr, us
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Marie-Camille Lafargue, Jean–Paul Duong Van Huyen, Pierre Isnard, Helmut G. Rennke et autres
Abstract Background and Aims Myelodysplastic syndromes (MDS) are hematologic disorders characterized by ineffective and dysplastic hematopoiesis that can be associated with systemic inflammatory and autoimmune diseases. The objective of this study was to describe kidney involvement in MDS patients, their treatments, and …
fr, us
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Marie-Camille Lafargue, Jean–Paul Duong Van Huyen, Pierre Isnard, Helmut G. Rennke et autres
Abstract Background and Aims Chronic myelomonocytic leukemia (CMML) is a hematologic disorder which is an overlap syndrome between myelodysplastic syndromes, and myeloproliferative neoplasms, and can be associated with autoimmune and inflammatory diseases. The objective of this study was to describe kidney involvement …
fr, us
(code pays fourni par la source)
2023
article
OpenAlex
Marie-Camille Lafargue, J.P. Duong Van Huyen, P. Isnard, Martin Carré et autres
fr, it, us
(code pays fourni par la source)
2023
article
OpenAlex
Marie-Camille Lafargue, J.P. Duong Van Huyen, P. Isnard, Marie Essig et autres
fr, us
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Marie-Camille Lafargue, Camille Cohen
fr
(code pays fourni par la source)